About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Dapagliflozin in Depression | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 1/2NCT07239011

Dapagliflozin in Depression

Major depressive disorder (MDD) is currently one of the leading causes of disability and suicidal death worldwide, and despite extensive research and massive improvements in mental health, the nature ...

Lead sponsor: Tanta University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Tanta University

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age ≥ 18 years Both male and female will be included Negative pregnancy test and effective contraception. Depressed patients for at least 2 months with Hamilton rating score more than 18.

Exclusion Criteria

•Patients with bipolar I or bipolar II disorder, personality disorders, and eating disorders.
•Patients with substance dependence or abuse Patients with history of seizures or receiving electroconvulsive therapy (ECT) Patients with inflammatory disorders Patients with allergy or contraindications to the used medications Patients with finally pregnant or lactating females Diabetic patients Sever kidney disorders

Related studies

RECRUITINGPhase 2

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more

RECRUITINGPhase 4

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

NCT06833788 · Postpartum Depression (PPD)

Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial

NCT06085950 · Treatment Resistant Depression

Multidimensional Sleep Health Intervention to Optimize Concussion Recovery

NCT07082218 · Concussion (Diagnosis), Concussion, Mild Traumatic Brain Injury, and more

RECRUITINGPhase 1

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

NCT05703685 · Depression

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 25, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE1/PHASE2

Enrollment60

Start dateNov 2025

Last updatedNov 25, 2025

Condition

Locations shown

Mostafa Bahaa

Damietta, New Damietta

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 25, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions